Skip to Content

Pfizer STN 12.5 mg (Sutent 12.5 mg)

Generic Name: sunitinib

Pill imprint Pfizer STN 12.5 mg has been identified as Sutent 12.5 mg.

Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Sutent 12.5 mg Pfizer STN 12.5 mg
Sutent 12.5 mg Pfizer STN 12.5 mg
Discount Card Promo
Sutent
Generic Name:
sunitinib
Imprint:
Pfizer STN 12.5 mg
Strength:
12.5 mg
Color:
Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC):
00069-0550
Inactive Ingredients:
mannitol
croscarmellose sodium
povidone k25
magnesium stearate
gelatin
titanium dioxide
ferric oxide red
shellac
propylene glycol
sodium hydroxide
povidone

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide